Simplex Trading
FHTX icon

Simplex Trading’s Foghorn Therapeutics FHTX Stock Holding History

Simplex Trading’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.23K Buy
1,892
+1,826
+2,767% +$8.1K ﹤0.01% 7752
2026
Q1 		$315 Buy
+66
New +$362 ﹤0.01% 8791
2025
Q3 		– Sell
-160
Closed -$848 – 9346
2025
Q2 		$0 Sell
160
-1,622
-91% -$6.78K ﹤0.01% 8963
2025
Q1 		$6K Buy
1,782
+1,102
+162% +$5.02K ﹤0.01% 7433
2024
Q4 		$3K Buy
+680
New +$4.95K ﹤0.01% 7869
2024
Q2 		– Sell
-2,119
Closed -$14K – 9074
2024
Q1 		$14K Buy
+2,119
New +$11.8K ﹤0.01% 7370
2023
Q1 		– Sell
-66
Closed – – 9334
2022
Q4 		$0 Buy
+66
New +$498 ﹤0.01% 9531
2022
Q2 		– Sell
-42
Closed -$542 – 10285
2022
Q1 		$0 Sell
42
-5,506
-99% -$75.6K ﹤0.01% 10690
2021
Q4 		$126K Buy
+5,548
New +$79.7K ﹤0.01% 5883

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Simplex Trading's FHTX Position: Q2 2026 in Review

Simplex Trading increased its Foghorn Therapeutics (FHTX) stake by 2,767% in Q2 2026, buying an estimated $8.1K and bringing the position to 1,892 shares worth $9.23K. The position accounts for ﹤0.01% of the portfolio, ranked #7752.

Simplex Trading first reported a position in FHTX in Q4 2021 and has held it in 9 quarters since. The position peaked at $126K in Q4 2021. 102 funds tracked by Wall St. Rank hold FHTX as of Q2 2026.

  • Simplex Trading held 1,892 shares of Foghorn Therapeutics worth $9.23K as of Q2 2026.
  • Simplex Trading bought 1,826 Foghorn Therapeutics shares in Q2 2026, an estimated $8.1K.
  • Foghorn Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7752 holding.
  • Simplex Trading first reported a position in Foghorn Therapeutics in Q4 2021 and has held it in 9 quarters since.
  • Simplex Trading's Foghorn Therapeutics position peaked at $126K in Q4 2021.
  • 102 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.